Brief: Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline At 2023 Asco Annual Meeting
03/06/2023 14:20
Blueprint Medicines Corp BPMC.O :
* BLUEPRINT MEDICINES HIGHLIGHTS CLINICAL PROGRESS ACROSS
PRECISION ONCOLOGY PIPELINE AT 2023 ASCO ANNUAL MEETING
Source text for Eikon: ID:nPn1KYN1ha
Further company coverage: BPMC.O
Recent news on Blueprint Medicines
See all newsBrief: Sanofi Announces Extension Of Blueprint Tender Offer
Brief: Blueprint Medicines Announces Data Reinforcing Safety Profile Of Long-Term Ayvakit
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G